Table 1 Patient characteristics

From: Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

Characteristics

N (%)

Sex

 Male

23 (74)

 Female

8 (26)

Age

 Median

58

 Range

40-83

Performance status

 0

20 (64)

 1

10 (34)

 2

1 (2)

Tumour histology

 Clear-cell carcinoma

31 (100)

Response to sunitinib

 Partial response

13 (42)

 Stable disease

4 (13)

 Progression

14 (45)

Previous treatment lines

 None

13 (42)

 1

11 (35)

 2

3 (10)

 ⩾3

4 (13)

Previous treatments

 Low-dose cytokines

15 (48)

 Bevacizumab

6 (19)

 Other

5 (16)

Back to article page